CSN Login
Members Online: 3

You are here

Anlotinib: a novel multi-targeting TKI treatment

lobbyist0724's picture
Posts: 471
Joined: Sep 2016

It is exciting to see more new treatments being available.


Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development.


Subscribe to Comments for "Anlotinib: a novel multi-targeting TKI treatment"